Mario A. Henriquez

Nephrology

170 W 233rd St
Bronx, NY 10463

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3 publications

Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHAT.

Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHAT.

Journal: Clinical nephrology

Published: July 03, 2013

Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.

Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: April 12, 2012

Cardiovascular risk assessment: addition of CKD and race to the Framingham equation.

Cardiovascular risk assessment: addition of CKD and race to the Framingham equation.

Journal: American heart journal

Published: October 17, 2011

Showing 1-3 of 3

Last Updated: 09/26/2026